| Synonyms: | |
| Status: | Approved (2007) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent Prodrug |
| ATC: | N06BA12 |
| UNII: | H645GUL8KJ |
Structure
| InChI Key | VOBHXZCDAVEXEY-JSGCOSHPSA-N |
|---|---|
| Smile | |
| InChI |
|
Physicochemical Descriptors
| Property Name | Value |
|---|---|
| Molecular Formula | C15H25N3O |
| Molecular Weight | 263.38 |
| AlogP | 1.19 |
| Hydrogen Bond Acceptor | 3.0 |
| Hydrogen Bond Donor | 3.0 |
| Number of Rotational Bond | 8.0 |
| Polar Surface Area | 81.14 |
| Molecular species | BASE |
| Aromatic Rings | 1.0 |
| Heavy Atoms | 19.0 |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Attention Deficit Disorder with Hyperactivity | 4 | D001289 | ClinicalTrials |
| Bipolar Disorder | 3 | D001714 | ClinicalTrials |
| Feeding and Eating Disorders | 3 | D001068 | ClinicalTrials |
| Depressive Disorder | 3 | D003866 | ClinicalTrials |
| Cocaine-Related Disorders | 2 | D019970 | ClinicalTrials |
| Multiple Sclerosis | 2 | D009103 | ClinicalTrials |
| Amphetamine-Related Disorders | 1 | D019969 | ClinicalTrials |
Related Entries
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 608137-32-2 |
| ChEBI | 135925 |
| ChEMBL | CHEMBL1201222 |
| DrugBank | DB01255 |
| DrugCentral | 4135 |
| EPA CompTox | DTXSID00209652 |
| FDA SRS | H645GUL8KJ |
| Human Metabolome Database | HMDB0015385 |
| Guide to Pharmacology | 7213 |
| PubChem | 11597698 |
| SureChEMBL | SCHEMBL158949 |
| ZINC | ZINC000011680943 |
CONTENTS